In the article “Nanochon Raises $4.1M to Advance Cartilage Repair Innovation into First-in-Human Clinical Study,” BioBuzz news reports that U.S.-based medical device startup Nanochon, co-founded by GW Engineering alumnus Ben Holmes, Ph.D. ‘16, has raised $4.1 million in Seed Prime II financing. This funding will support Nanochon’s first human clinical trial of its 3D printed knee implant.
Here is an excerpt from the article: “Leadership sees the current raise as a validation not only of the technology, but of the broader execution plan. Chief executive officer and co-founder Ben Holmes emphasized that investor support extends beyond capital, pointing to strategic input around regulatory planning, commercialization, and long-term scale as Nanochon enters its clinical phase.”
Read the full article on BioBuzz News. For more coverage, check out the Washington Business Journal.